Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Vue générale

  • Chapter
Tumeurs malignes rares

  • 56 Accesses

Résumé

Le terme général de «tumeur endocrine» (TE) (1) désigne toute tumeur développée à partir des cellules du système endocrinien diffus, caractérisée par ses capacités sécrétoires indépendamment de son siège et de son origine embryologique endodermique ou neuro-ectodermique. Le carcinome médullaire thyroïdien est exclu de cette définition.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Références

  1. Solcia E, Sessa F, Rindi G, et al. (1990) Classification and histogenesis of gastroenteropancreatic endocrine tumours. Eur J Clin Invest 20 (Suppl 1): S72–81

    PubMed  Google Scholar 

  2. Williams ED, Sandler M (1963) The classification of carcinoid tumors. Lancet I: 238

    Article  Google Scholar 

  3. Solcia E, Klöppel G, Sobin L (2000) Histological typing of endocrine tumours. 2nd ed. Berlin: World Health Organization — International Histological Classification of Tumours

    Google Scholar 

  4. Gatta G, Ciccolallo L, Kunkler I, et al. (2006) Survival from rare cancer in adults: a population-based study. Lancet Oncol 7: 132–40

    Article  PubMed  Google Scholar 

  5. Newton JN, Swerdlow AJ, dos Santos Silva IM, et al. (1994) The epidemiology of carcinoid tumours in England and Scotland. Br J Cancer 70: 939–42

    Article  CAS  PubMed  Google Scholar 

  6. Lepage C, Bouvier AM, Phelip JM, et al. (2004) Incidence and management of malignant digestive endocrine tumours in a well defined French population. Gut 53: 549–53

    Article  CAS  PubMed  Google Scholar 

  7. Crocetti E (1997) Gastrointestinal carcinoid tumours. A population-based study. Ital J Gastroenterol Hepatol 29: 135–137

    CAS  PubMed  Google Scholar 

  8. Hemminki K, Li X (2001) Incidence trends and risk factors of carcinoid tumors. Cancer 92: 2204–10

    Article  CAS  PubMed  Google Scholar 

  9. Hainsworth JD, Johnson MH, Greco A (1988) Poorly differentiated neuroendocrine carcinoma of unknown primary site. Ann Intern Med 109: 364–371

    CAS  PubMed  Google Scholar 

  10. Moertel CG, Kvols LK, O’Connell MJ, Rubin J (1991) Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Cancer 68: 227–32

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d’hépato-gastro-entérologie et oncologie digestive CHU Ambroise-Paré Assistance Publique-Hôpitaux de Paris, Université Versailles Saint-Quentin UFR de médecine Paris-Ile-de-France-Ouest, 9, avenue Charles-de-Gaulle, 92100, Boulogne

    E. Mitry

Authors
  1. E. Mitry
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Mitry, E. (2010). Vue générale. In: Tumeurs malignes rares. Springer, Paris. https://doi.org/10.1007/978-2-287-72070-3_32

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-72070-3_32

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-72069-7

  • Online ISBN: 978-2-287-72070-3

Publish with us

Policies and ethics

Search

Navigation